NEW HAVEN, Conn., April 26, 2018 /PRNewswire/ -- Surrounded by the best in Connecticut Entrepreneurialism, New
"It's a tremendous honor to have won Pre-Revenue Venture of the Year, in addition to our honorable mention," said David Light, founder and CEO of Valisure. "We at Valisure are absolutely thrilled to be celebrated for our hard work to bring patients the highest quality medications."
The CT Entrepreneur Awards identify, recognize, and celebrate Connecticut's leading entrepreneurs, ventures, and ecosystem elements that support them.
About ValisureValisure is developing cutting edge, laser-based technology to address rising medication quality concerns over counterfeits, generics and overseas manufacturing. This state-of-the-art process will ensure that consumers receive consistent medications that are screened and validated, assuring quality and consistency. Based in New Haven, Connecticut, Valisure was founded at Yale Science Park by a team of Yale University alumni with expertise in the fields of chemistry, molecular biology, pharmacology, and statistics. Valisure has ISO 17025 accreditation and is DEA and FDA registered. For more information, please visit www.valisure.com or follow @Valisure on Twitter.
RUBENSTEIN PUBLIC RELATIONSCONTACT: ALEXANDRA JIRSTRAND(212) 805-3022AJIRSTRAND@RUBENSTEINPR.COM
View original content:http://www.prnewswire.com/news-releases/valisure-wins-pre-revenue-venture-of-the-year-in-2018-ct-entrepreneur-awards-300637428.html
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All